- Home
- ILMN vs JLL Comparison
ILMN vs JLL Comparison
Compare ILMN & JLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- JLL
- Stock Information
- Founded
- ILMN 1998
- JLL 1997
- Country
- ILMN United States
- JLL United States
- Employees
- ILMN N/A
- JLL N/A
- Industry
- ILMN Medical Specialities
- JLL Real Estate
- Sector
- ILMN Health Care
- JLL Finance
- Exchange
- ILMN Nasdaq
- JLL Nasdaq
- Market Cap
- ILMN 16.0B
- JLL 14.5B
- IPO Year
- ILMN 2000
- JLL 1997
- Fundamental
- Price
- ILMN $97.68
- JLL $307.71
- Analyst Decision
- ILMN Buy
- JLL Buy
- Analyst Count
- ILMN 15
- JLL 8
- Target Price
- ILMN $123.67
- JLL $328.57
- AVG Volume (30 Days)
- ILMN 1.4M
- JLL 440.1K
- Earning Date
- ILMN 11-03-2025
- JLL 08-06-2025
- Dividend Yield
- ILMN N/A
- JLL N/A
- EPS Growth
- ILMN N/A
- JLL 47.74
- EPS
- ILMN 7.91
- JLL 11.64
- Revenue
- ILMN $4,284,000,000.00
- JLL $24,676,200,000.00
- Revenue This Year
- ILMN N/A
- JLL $12.26
- Revenue Next Year
- ILMN $2.76
- JLL $8.77
- P/E Ratio
- ILMN $12.29
- JLL $26.37
- Revenue Growth
- ILMN N/A
- JLL 13.47
- 52 Week Low
- ILMN $68.70
- JLL $194.36
- 52 Week High
- ILMN $156.66
- JLL $308.61
- Technical
- Relative Strength Index (RSI)
- ILMN 47.14
- JLL 69.34
- Support Level
- ILMN $95.44
- JLL $295.17
- Resistance Level
- ILMN $100.44
- JLL $308.42
- Average True Range (ATR)
- ILMN 2.48
- JLL 6.11
- MACD
- ILMN -0.41
- JLL -0.64
- Stochastic Oscillator
- ILMN 38.49
- JLL 95.05
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About JLL Jones Lang LaSalle Incorporated
Jones Lang LaSalle provides a wide range of real estate-related services to owners, occupiers, and investors worldwide, including leasing, property and project management, and capital markets advisory. JLL's investment management arm, LaSalle Investment Management, manages over $74 billion for clients across diverse public and private real estate strategies.